Advertisement

Impact and Diagnosis of Minimal or Grade 1 Hepatic Encephalopathy

  • Mette Munk Lauridsen
  • Hendrik Vilstrup
Chapter

Abstract

Two case stories are presented to illustrate how and in whom minimal and grade 1 hepatic encephalopathy should be diagnosed. By definition the use of psychometric or neurophysiological tests is necessary for identifying minimal HE and such tests are also very useful for description of grad 1 HE. We put emphasis on how to apply and interpret the tests in clinical practise, i.e. in patients with differing cognitive prerequisites and co-morbid diseases. Further, the case stories highlight how fluctuating minimal and grade 1 HE impinges on the lives of patients and caregivers.

Keywords

Diagnosis Psychometric tests Quality of life Fitness to drive Balance 

References

  1. 1.
    Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014;60(2):715–35.CrossRefPubMedGoogle Scholar
  2. 2.
    Gluud LL, Vilstrup H, Morgan MY. The effect of treatment for hepatic encephalopathy with nonabsorbable disaccarides on morbidity and mortality in patients with cirrhosis: systematic review and meta-analysis. In: Jalan R, editor. EASL International Liver Congress 2015; Vienna. ILC 2015 Abstract Book: EASL; 2015. p. 175.Google Scholar
  3. 3.
    Lauridsen MM, Thacker LR, White MB, Unser A, Sterling RK, Stravitz RT, et al. In patients with cirrhosis, driving simulator performance is associated with real-life driving. Clin Gastroenterol Hepatol. 2016;14(5):747–52.CrossRefPubMedGoogle Scholar
  4. 4.
    Yildirim M. Falls in patients with liver cirrhosis. Gastroenterol Nurs. 2017;40(4):306–10.CrossRefPubMedGoogle Scholar
  5. 5.
    Lauridsen MM, Mikkelsen S, Svensson T, Holm J, Kluver C, Gram J, et al. The continuous reaction time test for minimal hepatic encephalopathy validated by a randomized controlled multi-modal intervention—a pilot study. PLoS One. 2017;12(10):e0185412.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Lauridsen MM, Schaffalitzky de Muckadell OB, Vilstrup H. Minimal hepatic encephalopathy characterized by parallel use of the continuous reaction time and portosystemic encephalopathy tests. Metab Brain Dis. 2015;30(5):1187–92.CrossRefPubMedGoogle Scholar
  7. 7.
    Lauridsen MM, Poulsen L, Rasmussen CK, Hogild M, Nielsen MK, de Muckadell OB, et al. Effects of common chronic medical conditions on psychometric tests used to diagnose minimal hepatic encephalopathy. Metab Brain Dis. 2015;31(2):267–72.CrossRefPubMedGoogle Scholar
  8. 8.
    Lauridsen MM, Frojk J, de Muckadell OB, Vilstrup H. Opposite effects of sleep deprivation on the continuous reaction times in patients with liver cirrhosis and normal persons. Metab Brain Dis. 2014;29(3):655–60.CrossRefPubMedGoogle Scholar
  9. 9.
    Lauridsen MM, Thiele M, Kimer N, Vilstrup H. The continuous reaction times method for diagnosing, grading, and monitoring minimal/covert hepatic encephalopathy. Metab Brain Dis. 2013;28:231–4.CrossRefPubMedGoogle Scholar
  10. 10.
    Lauridsen MM, Gronbaek H, Naeser EB, Leth ST, Vilstrup H. Gender and age effects on the continuous reaction times method in volunteers and patients with cirrhosis. Metab Brain Dis. 2012;27:559–65.CrossRefPubMedGoogle Scholar
  11. 11.
    Lauridsen MM, Jepsen P, Vilstrup H. Critical flicker frequency and continuous reaction times for the diagnosis of minimal hepatic encephalopathy: a comparative study of 154 patients with liver disease. Metab Brain Dis. 2011;26(2):135–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Weissenborn K. Neuropsychological characterization of hepatic encephalopathy. J Hepatol. 2001;34:768–73.CrossRefPubMedGoogle Scholar
  13. 13.
    Lauridsen MM, Bajaj JS. Hepatic encephalopathy treatment and driving: a continental divide. J Hepatol. 2015;63:287–8.CrossRefPubMedGoogle Scholar
  14. 14.
    Schomerus H, Hamster W. Neuropsychological aspects of portal-systemic encephalopathy. Metab Brain Dis. 1998;13(4):361–77.CrossRefPubMedGoogle Scholar
  15. 15.
    Amodio P, Montagnese S, Spinelli G, Schiff S, Mapelli D. Cognitive reserve is a resilience factor for cognitive dysfunction in hepatic encephalopathy. Metab Brain Dis. 2017;32(4):1287–93.CrossRefPubMedGoogle Scholar
  16. 16.
    Patel AV, Wade JB, Thacker LR, Sterling RK, Siddiqui MS, Stravitz RT, et al. Cognitive reserve is a determinant of health-related quality of life in patients with cirrhosis, independent of covert hepatic encephalopathy and model for end-stage liver disease score. Clin Gastroenterol Hepatol. 2015;13(5):987–91.CrossRefPubMedGoogle Scholar
  17. 17.
    Bajaj JS, Wade JB, Gibson DP, Heuman DM, Thacker LR, Sterling RK, et al. The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers. Am J Gastroenterol. 2011;106(9):1646–53.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Jepsen P, Ott P, Andersen PK, Sorensen HT, Vilstrup H. Clinical course of alcoholic liver cirrhosis: a Danish population-based cohort study. Hepatology. 2010;51(5):1675–82.CrossRefPubMedGoogle Scholar
  19. 19.
    Sharma P, Sharma BC, Agrawal A, Sarin SK. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose. J Gastroenterol Hepatol. 2012;27:1329–35.CrossRefPubMedGoogle Scholar
  20. 20.
    Ladegaard Gronkjaer L, Hoppe Sehstedt T, Norlyk A, Vilstrup H. Overt hepatic encephalopathy experienced by individuals with cirrhosis: a qualitative interview study. Gastroenterol Nurs. 2017;  https://doi: 10.1097/SGA.0000000000000286. [Epub ahead of print]
  21. 21.
    Groeneweg M, Quero JC, De Bruijn I, Hartmann IJ, Essink-bot ML, Hop WC, et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology. 1998;28(1):45–9.CrossRefPubMedGoogle Scholar
  22. 22.
    Orr JG, Homer T, Ternent L, Newton J, McNeil CJ, Hudson M, et al. Health related quality of life in people with advanced chronic liver disease. J Hepatol. 2014;61(5):1158–65.CrossRefPubMedGoogle Scholar
  23. 23.
    Marchesini G, Bianchi G, Amodio P, Salerno F, Merli M, Panella C, et al. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology. 2001;120(1):170–8.CrossRefPubMedGoogle Scholar
  24. 24.
    Barboza KC, Salinas LM, Sahebjam F, Jesudian AB, Weisberg IL, Sigal SH. Impact of depressive symptoms and hepatic encephalopathy on health-related quality of life in cirrhotic hepatitis C patients. Metab Brain Dis. 2016;31(4):869–80.CrossRefPubMedGoogle Scholar
  25. 25.
    Kircheis G, Knoche A, Hilger N, Manhart F, Schnitzler A, Schulze H, et al. Hepatic encephalopathy and fitness to drive. Gastroenterology. 2009;137(5):1706–15.e1–9.CrossRefPubMedGoogle Scholar
  26. 26.
    Wein C, Koch H, Popp B, Oehler G, Schauder P. Minimal hepatic encephalopathy impairs fitness to drive. Hepatology. 2004;39(3):739–45.CrossRefPubMedGoogle Scholar
  27. 27.
    Bajaj JS, Saeian K, Schubert CM, Hafeezullah M, Franco J, Varma RR, et al. Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test. Hepatology. 2009;50(4):1175–83.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Urios A, Mangas-Losada A, Gimenez-Garzo C, Gonzalez-Lopez O, Giner-Duran R, Serra MA, et al. Altered postural control and stability in cirrhotic patients with minimal hepatic encephalopathy correlate with cognitive deficits. Liver Int. 2017;37(7):1013–22.CrossRefPubMedGoogle Scholar
  29. 29.
    Soriano G, Roman E, Cordoba J, Torrens M, Poca M, Torras X, et al. Cognitive dysfunction in cirrhosis is associated with falls: a prospective study. Hepatology. 2012;55(6):1922–30.CrossRefPubMedGoogle Scholar
  30. 30.
    Tips for preventing falls. Am Fam Physician. 2017;96(4): https://www.aafp.org/afp/2017/0815/p240-s1.html
  31. 31.
    Bajaj JS, Heuman DM, Sterling RK, Sanyal AJ, Siddiqui M, Matherly S, et al. Validation of EncephalApp, Smartphone-Based Stroop Test, for the Diagnosis of Covert Hepatic Encephalopathy. Clin Gastroenterol Hepatol. 2015;13(10):1828–1835.e1.CrossRefPubMedGoogle Scholar
  32. 32.
    Bajaj JS, Thacker LR, Heuman DM, Fuchs M, Sterling RK, Sanyal AJ, et al. The Stroop smartphone application is a short and valid method to screen for minimal hepatic encephalopathy. Hepatology. 2013;58(3):1122–32.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Kircheis G, Hilger N, Haussinger D. Value of critical flicker frequency and psychometric hepatic encephalopathy score in diagnosis of low-grade hepatic encephalopathy. Gastroenterology. 2014;146(4):961–9.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Gastroenterology and HepatologyHospital of South West JutlandEsbjergDenmark
  2. 2.Department of Hepatology and GastroenterologyAarhus University HospitalAarhusDenmark

Personalised recommendations